JP2024001036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024001036A5 JP2024001036A5 JP2023150377A JP2023150377A JP2024001036A5 JP 2024001036 A5 JP2024001036 A5 JP 2024001036A5 JP 2023150377 A JP2023150377 A JP 2023150377A JP 2023150377 A JP2023150377 A JP 2023150377A JP 2024001036 A5 JP2024001036 A5 JP 2024001036A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- chelating agent
- day
- antibiotic
- inhalable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 26
- 239000002738 chelating agent Substances 0.000 claims 16
- 230000003115 biocidal effect Effects 0.000 claims 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 8
- 239000003242 anti bacterial agent Substances 0.000 claims 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 210000004072 lung Anatomy 0.000 claims 3
- 229960000707 tobramycin Drugs 0.000 claims 3
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims 3
- QBYMCVQZZZQPHE-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;calcium Chemical group [Ca].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O QBYMCVQZZZQPHE-UHFFFAOYSA-N 0.000 claims 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 2
- 229940088710 antibiotic agent Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000002826 nitrites Chemical class 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017902364 | 2017-06-20 | ||
| AU2017902364A AU2017902364A0 (en) | 2017-06-20 | Method For Reducing Lung Infection | |
| AU2018900765A AU2018900765A0 (en) | 2018-03-08 | Method for Reducing Lung Infection | |
| AU2018900765 | 2018-03-08 | ||
| JP2019571249A JP7389653B2 (ja) | 2017-06-20 | 2018-06-20 | 肺感染症を低減させる方法 |
| PCT/AU2018/050610 WO2018232453A1 (en) | 2017-06-20 | 2018-06-20 | Method for reducing lung infection |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571249A Division JP7389653B2 (ja) | 2017-06-20 | 2018-06-20 | 肺感染症を低減させる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024001036A JP2024001036A (ja) | 2024-01-09 |
| JP2024001036A5 true JP2024001036A5 (https=) | 2024-03-08 |
| JP7642033B2 JP7642033B2 (ja) | 2025-03-07 |
Family
ID=64735417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571249A Active JP7389653B2 (ja) | 2017-06-20 | 2018-06-20 | 肺感染症を低減させる方法 |
| JP2023150377A Active JP7642033B2 (ja) | 2017-06-20 | 2023-09-15 | 肺感染症を低減させる方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571249A Active JP7389653B2 (ja) | 2017-06-20 | 2018-06-20 | 肺感染症を低減させる方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11382884B2 (https=) |
| EP (1) | EP3641750A4 (https=) |
| JP (2) | JP7389653B2 (https=) |
| CN (1) | CN111065386A (https=) |
| AU (3) | AU2018286650B2 (https=) |
| BR (1) | BR112019027255A2 (https=) |
| CA (1) | CA3067858A1 (https=) |
| WO (1) | WO2018232453A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210361581A1 (en) * | 2018-10-22 | 2021-11-25 | Ioi Oleo Gmbh | Additive for a powder material intended for compaction into shaped bodies |
| CN116173037A (zh) * | 2023-04-14 | 2023-05-30 | 中国人民解放军总医院 | 咖啡因在预防和/或治疗急性高原病中的应用 |
| US20250108004A1 (en) * | 2023-09-29 | 2025-04-03 | Sterilecare Inc. | Aerosol delivery of edta compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| WO2008137747A1 (en) | 2007-05-02 | 2008-11-13 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
| WO2011142677A1 (en) * | 2010-05-11 | 2011-11-17 | Breathe Easy Ltd | Methods and compositions for the treatment of lung disorders |
| AU2016228976B2 (en) * | 2015-03-11 | 2018-11-08 | University Of Cincinnati | Compositions and methods for treating bacterial infection |
-
2018
- 2018-06-20 WO PCT/AU2018/050610 patent/WO2018232453A1/en not_active Ceased
- 2018-06-20 CN CN201880040947.1A patent/CN111065386A/zh active Pending
- 2018-06-20 BR BR112019027255-0A patent/BR112019027255A2/pt not_active Application Discontinuation
- 2018-06-20 JP JP2019571249A patent/JP7389653B2/ja active Active
- 2018-06-20 CA CA3067858A patent/CA3067858A1/en active Pending
- 2018-06-20 EP EP18821470.4A patent/EP3641750A4/en active Pending
- 2018-06-20 US US16/615,072 patent/US11382884B2/en active Active
- 2018-06-20 AU AU2018286650A patent/AU2018286650B2/en active Active
-
2023
- 2023-09-15 JP JP2023150377A patent/JP7642033B2/ja active Active
- 2023-12-21 AU AU2023285900A patent/AU2023285900B2/en active Active
-
2025
- 2025-10-24 AU AU2025256218A patent/AU2025256218A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001036A5 (https=) | ||
| Hallal et al. | Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study | |
| US9925206B2 (en) | Compositions and methods for treating bacterial infection | |
| Vendrell et al. | Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis | |
| JP2002532520A (ja) | 気道病治療および気道用薬剤送達のための化合物および方法 | |
| JP2015232026A (ja) | 人工呼吸器関連肺炎（ｖａｐ）及び人工呼吸器関連気管（ｖａｔ）気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム | |
| Li Bassi et al. | Endotracheal tube biofilm translocation in the lateral Trendelenburg position | |
| JP2020524172A5 (https=) | ||
| CN104784218A (zh) | 呼吸道益生菌粉 | |
| JP2023071952A5 (https=) | ||
| US8636984B2 (en) | Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | |
| Lake et al. | Combined topical pulmonary and systemic gentamicin: the question of safety | |
| Meyers et al. | Bacteriological, pharmacological, and clinical studies of carbenicillin | |
| Parker et al. | Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance | |
| CN102755337B (zh) | 复方氟苯尼考注射液及其制备方法 | |
| DUMA | Aztreonam, the first monobactam | |
| Thys et al. | Peak or sustained antibiotic serum levels for optimal tissue penetration | |
| Sande | Antimicrobial therapy for two serious bacterial infections: enterococcal endocarditis and nosocomial pneumonia | |
| CN113262197A (zh) | 一种治疗口腔溃疡的复方凝胶及其制备方法 | |
| Thadepalli et al. | Anaerobic lung infections treated with doxycycline | |
| Holliday et al. | Effects of Nasal Alkalinization on Bacterial Colonization in Healthy Subjects | |
| Hynes | XV Penicillin Aerosol Therapy in Sinusitis | |
| Chacko et al. | Is it the end of the road for inhaled antibiotic therapy in ventilator-associated pneumonia? | |
| Raschke | PMH, FH, SH | |
| US20180008598A1 (en) | Antibacterial nasal compositions and related methods |